Literature DB >> 22555113

Practice patterns in evaluation of living kidney donors in United Network for Organ Sharing-approved kidney transplant centers.

Amarpali Brar1, Rahul M Jindal, Kevin C Abbott, Frank P Hurst, Moro O Salifu.   

Abstract

INTRODUCTION: The current pattern of evaluation for living kidney donors was investigated.
METHODS: We designed a 37-question electronic survey to collect information about living kidney donor evaluation. Of the 181 United Network for Organ Sharing (UNOS)-approved centers, 72 responded. Survey responses were coded and downloaded into SPSS. Data was expressed as means and standard deviations or the percentage of centers with specific responses.
RESULTS: 66% of the centers used a cut-off of <80 ml/min for exclusion of living kidney donors. 24-hour urine measuring creatinine clearance (CrCl) was the most common screening method for glomerular filtration rate (GFR) assessment in potential living donors. 56% of the centers excluded donors with blood pressure (BP) >140/90, whereas 22.7 and 7.1% excluded patients with pre-hypertension with a cut-off BP of 130/85 and 120/80, respectively. 66% of the centers used 24-hour urine creatinine to assess for proteinuria. 20% of the centers accepted living kidney donors with microalbuminuria and 84% accepted patients with a history of nephrolithiasis. 24% of the centers reported use of formal cognitive testing of potential living donors. DISCUSSION: There were significant variations in exclusion criteria based on GFR, history of kidney stones, body mass index, BP and donors with urinary abnormalities. The definitions for hematuria and proteinuria were variable. There is a need for uniformity in selection and for a living donor registry. We also recommend raising the cut-off for estimated GFR to 90 ml/min to account for 10-15% overestimation when CrCl is used.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22555113     DOI: 10.1159/000338450

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

1.  Obesity increases the risk of end-stage renal disease among living kidney donors.

Authors:  Jayme E Locke; Rhiannon D Reed; Allan Massie; Paul A MacLennan; Deirdre Sawinski; Vineeta Kumar; Shikha Mehta; Roslyn B Mannon; Robert Gaston; Cora E Lewis; Dorry L Segev
Journal:  Kidney Int       Date:  2016-12-29       Impact factor: 10.612

2.  Mood, body image, fear of kidney failure, life satisfaction, and decisional stability following living kidney donation: Findings from the KDOC study.

Authors:  J R Rodrigue; J D Schold; P Morrissey; J Whiting; J Vella; L K Kayler; D Katz; J Jones; B Kaplan; A Fleishman; M Pavlakis; D A Mandelbrot
Journal:  Am J Transplant       Date:  2018-01-09       Impact factor: 8.086

3.  The Efficiency of Evaluating Candidates for Living Kidney Donation: A Scoping Review.

Authors:  Steven Habbous; Justin Woo; Ngan N Lam; Krista L Lentine; Matthew Cooper; Marian Reich; Amit X Garg
Journal:  Transplant Direct       Date:  2018-09-20

4.  Outcomes of Renal Stone Surgery Performed Either as Predonation or Ex Vivo Bench Procedure in Renal Grafts from Living Donors: A Systematic Review.

Authors:  Nicola Longo; Armando Calogero; Massimiliano Creta; Giuseppe Celentano; Luigi Napolitano; Marco Capece; Roberto La Rocca; Caterina Sagnelli; Nicola Carlomagno; Gaia Peluso; Teresa Pagano; Silvia Campanile; Concetta Anna Dodaro; Antonello Sica; Gianluigi Califano; Felice Crocetto; Ferdinando Fusco; Francesco Mangiapia; Michele Santangelo
Journal:  Biomed Res Int       Date:  2020-11-27       Impact factor: 3.411

5.  Kidney Perfusion in Contrast-Enhanced Ultrasound (CEUS) Correlates with Renal Function in Living Kidney Donors.

Authors:  Nasrin El-Bandar; Markus H Lerchbaumer; Robert Peters; Andreas Maxeiner; Katja Kotsch; Arne Sattler; Kurt Miller; Thorsten Schlomm; Bernd Hamm; Klemens Budde; Lutz Liefeldt; Thomas Fischer; Frank Friedersdorff
Journal:  J Clin Med       Date:  2022-02-01       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.